Effectiveness of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Group Format: An efficient proposal for public health (Q3160076): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): Emotional Disorders (TE, anxiety and mood disorders) are the most prevalent in our society and generate very high direct and indirect costs in our SNS. Mental Health professionals should know and apply specific treatments for each of the TEs, with the cost involved. In addition, the long waiting lists in the Public Mental Health Systems pose the challenge of testing new psychological treatments and intervention formats. Recent research has ident...) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
Effectiveness of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Group Format: An efficient proposal for public health | |||
Revision as of 16:30, 12 October 2021
Project Q3160076 in Spain
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effectiveness of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Group Format: An efficient proposal for public health |
Project Q3160076 in Spain |
Statements
36,950.0 Euro
0 references
73,900.0 Euro
0 references
50.0 percent
0 references
1 January 2018
0 references
31 March 2021
0 references
INSTITUTO DE INVESTIGACION SANITARIA ARAGON
0 references
41°39'7.67"N, 0°52'51.38"W
0 references
50297
0 references
Los Trastornos Emocionales (TE, trastornos de ansiedad y del estado de ánimo) son los de mayor prevalencia en nuestra sociedad y generan unos costes, directos e indirectos, muy elevados en nuestro SNS. Los profesionales de la Salud Mental deben conocer y aplicar tratamientos específicos para cada uno de los TE, con el coste que supone. Además, las largas listas de espera en los Sistemas Públicos de Salud Mental plantean el reto de someter a prueba nuevos tratamientos psicológicos y formatos de intervención. La investigación reciente ha identificado factores etiológicos comunes a los distintos TE (perspectiva transdiagnóstica) lo que ha generado la aparición de nuevas propuestas de tratamiento psicológico. Una de las más reconocidas es el “Protocolo Unificado para el Tratamiento Transdiagnóstico de los Trastornos Emocionales” (PU) del Dr. David H. Barlow, que incide en la disregulación emocional característica de los TE. El PU cuenta con datos de eficacia en su aplicación individual y grupal. Presentamos un ensayo clínico aleatorizado multicéntrico para estudiar la eficacia y coste-efectividad del PU aplicado en grupo en distintos dispositivos del SNS. Nuestro objetivo es hacer llegar a la práctica clínica (investigación clínica-traslacional) la innovación conseguida a nivel psicopatológico y de tratamientos basados en la evidencia. (Spanish)
0 references
Emotional Disorders (TE, anxiety and mood disorders) are the most prevalent in our society and generate very high direct and indirect costs in our SNS. Mental Health professionals should know and apply specific treatments for each of the TEs, with the cost involved. In addition, the long waiting lists in the Public Mental Health Systems pose the challenge of testing new psychological treatments and intervention formats. Recent research has identified etiological factors common to different ETs (transdiagnostic perspective) which has led to the emergence of new proposals for psychological treatment. One of the most recognised is the “Unified Protocol for Transdiagnostic Treatment of Emotional Disorders” (PU) by Dr. David H. Barlow, which affects the emotional dysregulation characteristic of ESDs. The PU has data of effectiveness in its individual and group application. We present a multicenter randomised clinical trial to study the efficacy and cost-effectiveness of PU applied as a group in different NHS devices. Our goal is to bring to clinical practice (clinical-translational research) the innovation achieved at the psychopathological level and evidence-based treatments. (English)
12 October 2021
0 references
Zaragoza
0 references
Identifiers
PI17_00320
0 references